Charles Liss

1.5k total citations
39 papers, 1.1k citations indexed

About

Charles Liss is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Charles Liss has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Charles Liss's work include Blood Pressure and Hypertension Studies (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Hormonal Regulation and Hypertension (6 papers). Charles Liss is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Hormonal Regulation and Hypertension (6 papers). Charles Liss collaborates with scholars based in United States, Japan and France. Charles Liss's co-authors include David S. Fedson, Gilbert Block, Donald W. Nibbelink, Joseph Irr, Scott A. Reines, Jonathan M. Edelman, Christine Byrnes, Eliav Barr, Jane E. Reagan and Brian W. Walsh and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Clinical Endocrinology & Metabolism and Journal of the American Society of Nephrology.

In The Last Decade

Charles Liss

36 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Liss United States	19	271	256	229	207	121	39	1.1k
Koichiro Yamamoto Japan	14	175 0.6×	128 0.5×	62 0.3×	88 0.4×	109 0.9×	80	810
Paula Abreu United States	17	235 0.9×	85 0.3×	151 0.7×	23 0.1×	22 0.2×	36	1.1k
Hongmei Zhang China	12	92 0.3×	94 0.4×	148 0.6×	421 2.0×	15 0.1×	45	1.3k
Philippe M. Frossard United Arab Emirates	21	390 1.4×	99 0.4×	361 1.6×	14 0.1×	12 0.1×	70	1.4k
C.J. Haines Hong Kong	20	72 0.3×	69 0.3×	357 1.6×	13 0.1×	88 0.7×	45	1.4k
Albina Nowak Switzerland	21	214 0.8×	467 1.8×	41 0.2×	33 0.2×	17 0.1×	94	1.5k
Xia Zhang China	17	75 0.3×	146 0.6×	87 0.4×	59 0.3×	12 0.1×	66	711
Attila Dunky Austria	19	149 0.5×	126 0.5×	174 0.8×	10 0.0×	46 0.4×	41	1.3k
K A Sobocinski United States	11	142 0.5×	195 0.8×	407 1.8×	26 0.1×	14 0.1×	16	1.7k
В. В. Фомин Russia	12	169 0.6×	178 0.7×	49 0.2×	50 0.2×	13 0.1×	179	855

Countries citing papers authored by Charles Liss

Since Specialization

Citations

This map shows the geographic impact of Charles Liss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Liss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Liss more than expected).

Fields of papers citing papers by Charles Liss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Liss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Liss. The network helps show where Charles Liss may publish in the future.

Co-authorship network of co-authors of Charles Liss

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Liss. A scholar is included among the top collaborators of Charles Liss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Liss. Charles Liss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brody, Robert S., Charles Liss, Heather Wray, et al.. (2017). Results from a drug utilization study of extended release quetiapine fumarate prescribed by psychiatrists as treatment for major depressive disorder in selected countries in the European Union. International Clinical Psychopharmacology. 33(2). 59–65. 1 indexed citations

Vesikari, Timo, Jason Martin, Charles Liss, et al.. (2011). Safety and Immunogenicity of a Modified Process Hepatitis B Vaccine in Healthy Infants. The Pediatric Infectious Disease Journal. 30(7). e109–e113. 5 indexed citations

Musher, Daniel M., Susan B. Manoff, Richard McFetridge, et al.. (2011). Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Human Vaccines. 7(9). 919–928. 65 indexed citations

Manoff, Susan B., Charles Liss, Michael J. Caulfield, et al.. (2010). Revaccination with a 23‐Valent Pneumococcal Polysaccharide Vaccine Induces Elevated and Persistent Functional Antibody Responses in Adults Aged ⩾65 Years. The Journal of Infectious Diseases. 201(4). 525–533. 58 indexed citations

Damme, Pierre Van, et al.. (2009). Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults. Human Vaccines. 5(2). 92–97. 24 indexed citations

Doherty, Richard, Suzanne M. Garland, Charles Liss, et al.. (2009). Effectiveness of a Bivalent Haemophilus influenzae Type b–Hepatitis B Vaccine in Preventing Hepatitis B Virus Infection Among Children Born to Hepatitis B e Antigen-Positive Carrier Mothers. The Pediatric Infectious Disease Journal. 28(9). 777–781. 3 indexed citations

Fedson, David S. & Charles Liss. (2003). Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine. 22(8). 927–946. 78 indexed citations

Davidson, Michael H., et al.. (2003). A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d. Clinical Therapeutics. 25(11). 2738–2753. 18 indexed citations

Maloney, Susan A., et al.. (1999). Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension. Clinical Therapeutics. 21(9). 1533–1538. 11 indexed citations

10.

Schenker, Howard I., et al.. (1999). Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma. Clinical Therapeutics. 21(1). 138–147. 41 indexed citations

11.

Lindsay, Robert, Felicia Cosman, Rogerio A. Løbo, et al.. (1999). Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial¹. The Journal of Clinical Endocrinology & Metabolism. 84(9). 3076–3081. 135 indexed citations

12.

Liss, Charles, et al.. (1998). A study of losartan, alone or with hydrochlorothiazide vs nifedipine GITS in elderly patients with diastolic hypertension. Journal of Human Hypertension. 12(10). 693–699. 22 indexed citations

13.

Block, Gilbert, Charles Liss, Scott A. Reines, Joseph Irr, & Donald W. Nibbelink. (1997). Comparison of Immediate-Release and Controlled Release Carbidopa/Levodopa in Parkinson’s Disease. European Neurology. 37(1). 23–27. 175 indexed citations

14.

Barr, Eliav, et al.. (1996). Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension. Clinical Therapeutics. 18(4). 608–625. 72 indexed citations

15.

Girman, Cynthia J., et al.. (1996). Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. The Prostate. 29(2). 83–90. 34 indexed citations

16.

Liss, Charles, et al.. (1996). Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension. Clinical Therapeutics. 18(3). 411–428. 46 indexed citations

17.

Barry, Michael J., et al.. (1995). The American Urological Association Symptom Index: Does Mode of Administration Affect its Psychometric Properties?. The Journal of Urology. 154(3). 1056–1059. 35 indexed citations

18.

Bloom, Bernard S., et al.. (1995). Omeprazole or Ranitidine Plus Metoclopramide for Patients with Severe Erosive Oesophagitis. PharmacoEconomics. 8(4). 343–349. 18 indexed citations

19.

Olanow, C. Warren, Paul A. Nausieda, B. V. Manyam, et al.. (1991). An Open Multicenter Trial of Sinemet CR in Levodopa-Naive Parkinsonʼs Disease Patients. Clinical Neuropharmacology. 14(3). 235–240. 15 indexed citations

20.

Шапиро, Д. А., et al.. (1987). Enalapril and Hydrochlorothiazide as Antihypertensive Agents in the Elderly. Journal of Cardiovascular Pharmacology. 10. 160–162. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact